409 related articles for article (PubMed ID: 18236999)
1. Montelukast treatment in children with moderately severe atopic dermatitis.
Ehlayel MS; Bener A; Sabbah A
Eur Ann Allergy Clin Immunol; 2007 Sep; 39(7):232-6. PubMed ID: 18236999
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
3. Brief case series: montelukast, at doses recommended for asthma treatment, reduces disease severity and increases soluble CD14 in children with atopic dermatitis.
Hon KL; Leung TF; Ma KC; Wong Y; Fok TF
J Dermatolog Treat; 2005 Feb; 16(1):15-8. PubMed ID: 15897161
[TBL] [Abstract][Full Text] [Related]
4. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
5. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.
Yanase DJ; David-Bajar K
J Am Acad Dermatol; 2001 Jan; 44(1):89-93. PubMed ID: 11148482
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults.
Capella GL; Grigerio E; Altomare G
Eur J Dermatol; 2001; 11(3):209-13. PubMed ID: 11358726
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
Papadopoulos NG; Philip G; Giezek H; Watkins M; Smugar SS; Polos PG
J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680
[TBL] [Abstract][Full Text] [Related]
9. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up.
Warner JO;
J Allergy Clin Immunol; 2001 Dec; 108(6):929-37. PubMed ID: 11742270
[TBL] [Abstract][Full Text] [Related]
10. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.
van Adelsberg J; Moy J; Wei LX; Tozzi CA; Knorr B; Reiss TF
Curr Med Res Opin; 2005 Jun; 21(6):971-9. PubMed ID: 15969897
[TBL] [Abstract][Full Text] [Related]
12. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
13. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.
Veien NK; Busch-Sørensen M; Stausbøl-Grøn B
J Am Acad Dermatol; 2005 Jul; 53(1):147-9. PubMed ID: 15965438
[TBL] [Abstract][Full Text] [Related]
14. Oral antihistamine therapy influences plasma tryptase levels in adult atopic dermatitis.
Kawakami T; Kaminishi K; Soma Y; Kushimoto T; Mizoguchi M
J Dermatol Sci; 2006 Aug; 43(2):127-34. PubMed ID: 16843643
[TBL] [Abstract][Full Text] [Related]
15. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
[TBL] [Abstract][Full Text] [Related]
16. Comparative effect of triamcinolone, nedocromil and montelukast on asthma control in children: A randomized pragmatic study.
Stelmach I; Majak P; Jerzynska J; Stelmach W; Kuna P
Pediatr Allergy Immunol; 2004 Aug; 15(4):359-64. PubMed ID: 15305946
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis.
Amirav I; Luder AS; Kruger N; Borovitch Y; Babai I; Miron D; Zuker M; Tal G; Mandelberg A
Pediatrics; 2008 Dec; 122(6):e1249-55. PubMed ID: 18984650
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years.
Nelson KA; Smith SR; Trinkaus K; Jaffe DM
Pediatr Emerg Care; 2008 Jan; 24(1):21-7. PubMed ID: 18165796
[TBL] [Abstract][Full Text] [Related]
19. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease.
Arkwright PD; David TJ
J Allergy Clin Immunol; 2001 Mar; 107(3):531-4. PubMed ID: 11240956
[TBL] [Abstract][Full Text] [Related]
20. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]